Cooper Cos. stock has fallen approximately 25% since a previous Barron's recommendation, prompting a re-evaluation of its market position. Despite the decline, the company's low valuation and aggressive share buyback program suggest it may now be an attractive investment opportunity.
Cooper Cos. Stock Appears Undervalued After 25% Decline
Cooper CompaniesMedical DevicesStock ValuationShare Buybacks

